Nothing Special   »   [go: up one dir, main page]

Skip to main content
Log in

Efficient Method Development and Validation for the Determination of Cardiovascular Drugs in Human Plasma by SPE–UHPLC–PDA–FLD

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

This work reports the development and validation of an ultra-high-performance liquid chromatography method to separate 11 different cardiovascular drugs: acenocoumarol, amiloride, bisoprolol, fluvastatin, furosemide, glibenclamide, hydrochlorothiazide, rosiglitazone (internal standard), valsartan, verapamil and warfarin. Detection of the analytes was carried out by means of photodiode array and fluorescence detection. Initially, the most significant variables in liquid chromatography (pH of the mobile phase, nature of the organic modifier and stationary phase type) were studied simultaneously in a systematic way. Taking into account the resolution obtained for the different chromatographic separations, pH 4.5, methanol and C18 were chosen as mobile phase pH, organic modifier and stationary phase, respectively. The method was validated and applied to the analysis of real human plasma samples using a solid phase extraction sample treatment, and the robustness of the chromatographic separation was studied by experimental design. The reported method allows the separation of all the analytes and the IS in less than 6 min, and, furthermore, it simplifies the analysis of drugs used in combined cardiovascular therapy by applying a fast and simple methodology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. World Health Organization (2015) Fact sheet: noncommunicable diseases. http://www.who.int/mediacentre/factsheets/fs355/en/. Accessed May 2015

  2. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, American Heart Association Statistics C, Stroke Statistics S (2016) Circulation 133:e38–e360

    Article  Google Scholar 

  3. Lafeber M, Spiering W, Visseren FL, Grobbee DE (2016) Curr Hypertens Rep 18:40

    Article  CAS  Google Scholar 

  4. Barrios V, Escobar C (2016) Future Cardiol 12:181–196

    Article  CAS  Google Scholar 

  5. Baranowska I, Wilczek A, Baranowski J (2010) Analy Sci: Int J Jpn Soc Anal Chem 26:755–759

    Article  CAS  Google Scholar 

  6. Dinç E, Ertekin C, Rouhani G (2015) J Liq Chromatogr Relat Technol 38:970–976

    Article  Google Scholar 

  7. Dobricic V, Vulovic-Tadic M, Jancinc-Stojanovic B, Vladimirov S, Cudina O (2016) Chromatographia 79:571–579

    Article  CAS  Google Scholar 

  8. Joshi SJ, Karbhari PA, Bhoir SI, Bindu KS, Das C (2010) J Pharm Biomed Anal 52:362–371

    Article  CAS  Google Scholar 

  9. Gonzalez O, Ferreiros N, Blanco ME, Alonso RM (2015) Bioanalysis 7:2399–2417

    Article  CAS  Google Scholar 

  10. Baranowska I, Magiera S, Baranowski J (2013) J Chromatogr B 927:54–79

    Article  CAS  Google Scholar 

  11. Soltani S, Ramezani AM, Soltani N, Jouyban A (2012) Bioanalysis 4:2805–2821

    Article  CAS  Google Scholar 

  12. Lasky T, Greenspan J, Ernst FR, Gonzalez L (2011) Clin Ther 33:2082–2088

    Article  CAS  Google Scholar 

  13. Dias E, Hachey B, McNaughton C, Nian H, Yu C, Straka B, Brown NJ, Caprioli RM (2013) J Chromatogr B 937:44–53

    Article  CAS  Google Scholar 

  14. Magiera S, Baranowska I, Kusa J (2012) Talanta 89:47–56

    Article  CAS  Google Scholar 

  15. Andre C, Jorge F, Castanheira I, Matos A (2013) J Chemom 27:91–98

    Article  CAS  Google Scholar 

  16. Zhou Y, Song J-Z, Choi FF-K, Wu H-F, Qiao C-F, Ding L-S, Gesang S-L, Xu H-X (2009) J Chromatogr A 1216:7013–7023

    Article  CAS  Google Scholar 

  17. Baranowska I, Magiera S, Baranowski J (2011) J Chromatogr B 879:615–626

    Article  CAS  Google Scholar 

  18. Snyder L, Kirkland J, Dolan J (2009) Introduction to modern liquid chromatography. Wiley, New Jersey

    Book  Google Scholar 

  19. European Medicines Agency (2011) EMEA/CHMP/EWP/192217/2009, guideline on bioanalytical method validation

  20. US Department of Health and Human Services, Food and Drug Administration (2001) Guidance for industry: bioanalytical method validation

  21. Esbensen K (2001) Multivariate data analysis in practice. CAMO, Oslo

    Google Scholar 

  22. Dejaegher B, Vander Heyden Y (2007) J Chromatogr A 1158:138–157

    Article  CAS  Google Scholar 

  23. Vander Heyden Y, Nijhuis A, Smeyers-Verbeke J, Vandeginste BGM, Massart DL (2001) J Pharm Biomed Anal 24:723–753

    Article  CAS  Google Scholar 

  24. Vander Heyden Y, Questier F, Massart DL (1998) J Pharm Biomed Anal 17:153–168

    Article  CAS  Google Scholar 

  25. W-d Zhang, W-j Yang, Wang X-j GuY, Wang R (2011) J Chromatogr B 879:3735–3741

    Article  Google Scholar 

  26. Tan KL, Ankathil R, Gan SH (2011) J Chromatogr B 879:3583–3591

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Authors thank Ministry of Economy and Competitiveness (Project CTQ2013- 46179R), University of Basque Country (GIU 16/04 and UFI 11/23) for financial support and the pharmaceutical companies for the kind supply of studied drugs. M. E. Blanco also thanks the University of the Basque Country (UPV/EHU) for her postdoctoral grant.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Oskar González Mendia.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

González Mendia, O., Blanco, M.E., Rico, E. et al. Efficient Method Development and Validation for the Determination of Cardiovascular Drugs in Human Plasma by SPE–UHPLC–PDA–FLD. Chromatographia 80, 605–615 (2017). https://doi.org/10.1007/s10337-017-3274-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-017-3274-6

Keywords

Navigation